Subcutaneous implantable cardioverter-defibrillator therapy in Poland: Results of the Polish S-ICD Registry.
Kempa M, Budrejko S, Tajstra M, Syska P, Lewandowski M, Fabiszak T, Michalak M, Stanek A, Nowak K, Mitkowski P, Kaczmarek K, Orski Z, Janowski M, Szafarz P, Filipecki A, Sokal A, Szołkiewicz M, Jagielski D, Przybylski A.
Kardiol Pol. 2023;81(5):455-462. doi: 10.33963/KP.a2023.0046. Epub 2023 Mar 5.
The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy.
Molnár L, Crozier I, Haqqani H, O'Donnell D, Kotschet E, Alison J, Thompson AE, Bhatia VA, Papp R, Zima E, Jermendy Á, Apor A, Merkely B.
Europace. 2022 May 3;24(5):762-773. doi: 10.1093/europace/euab243.
Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Jędrzejczyk-Patej E, Mazurek M, Kotalczyk A, Kowalska W, Konieczny-Kozielska A, Kozielski J, Podolecki T, Szulik M, Sokal A, Kowalski O, Kalarus Z, Średniawa B, Lenarczyk R.
Europace. 2021 Jan 27;23(1):113-122. doi: 10.1093/europace/euaa339.
Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
Yamazaki K, Ishida Y, Sasaki S, Toyama Y, Nishizaki K, Kinjo T, Itoh T, Kimura M, Sakai S, Shikanai S, Sorimachi Y, Hamaura S, Tomita H.
J Cardiol. 2022 Nov;80(5):482-486. doi: 10.1016/j.jjcc.2022.06.014. Epub 2022 Jul 25.
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study.
Gold MR, Aasbo JD, Weiss R, Burke MC, Gleva MJ, Knight BP, Miller MA, Schuger CD, Carter N, Leigh J, Brisben AJ, El-Chami MF.
Heart Rhythm. 2022 Dec;19(12):1993-2001. doi: 10.1016/j.hrthm.2022.07.031. Epub 2022 Aug 6.
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan.
Begisbayev T, Kosherbayeva L, Akhmetov V, Khvan D, Brimzhanova M.
Glob Heart. 2022 May 10;17(1):30. doi: 10.5334/gh.1119. eCollection 2022.
Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
Koman E, Gupta A, Subzposh F, Saltzman H, Kutalek SP.
J Interv Card Electrophysiol. 2016 Mar;45(2):219-23. doi: 10.1007/s10840-015-0093-2. Epub 2016 Jan 14.
Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Implantation in Patients With Brugada Syndrome.
Dereci A, Yap SC, Schinkel AFL.
JACC Clin Electrophysiol. 2019 Feb;5(2):141-148. doi: 10.1016/j.jacep.2018.09.005. Epub 2018 Nov 1.
Safety and feasibility of implanting a transvenous implantable cardioverter defibrillator (TV-ICD) in the left axilla.
Enomoto Y, Noro M, Toyoda Y, Ishii R, Asami M, Takagi T, Sahara N, Hashimoto H, Kujime S, Nakamura K, Hara H, Moroi M, Sugi K, Nakamura M.
Pacing Clin Electrophysiol. 2021 Nov;44(11):1810-1816. doi: 10.1111/pace.14362. Epub 2021 Oct 6.
The subcutaneous implantable cardioverter-defibrillator in review.
Kamp NJ, Al-Khatib SM.
Am Heart J. 2019 Nov;217:131-139. doi: 10.1016/j.ahj.2019.08.010. Epub 2019 Aug 17.
